Skip to main content

Effects of Intravenous Amiodarone on Refractory Periods of the His Purkinje System

  • Conference paper
Cardiac Pacing
  • 61 Accesses

Summary

In 4 patients an intrahisian second degree AV block occurred during oral amiodarone (Am) therapy (daily dose of 400 mg) and disappeared 3 months after the end of Am. To assess a relation between Am and intrahisian A V block, 150 mg of Am were injected in 26 patients (pts) with prolonged HV interval and/or infrahisian block induced by programmed atrial (A) extrastimulus technique. His Purkinje anterograde effective refractory period (HP ERP) was the longest HI H2 interval in which conduction to the ventricles failed to occur (H1 = His bundle electrogram of the A paced rhythm, H2: His bundle electrogram after the extrastimulus); HP functional RP (HP FRP) was the shortest propagated V1-V2 interval and HP relative RP (HP RRP) was the longest HI H2 interval with H2-V2 > H1-V1. The HP RP were studied before and after Am at the same A paced rhythm. HP-RP increased (2 to 12%) in 9pts; HP-AV-conduction was abnormal (spontaneous HV interval > 55 ms, HV interval after Ajmaline ≥ 100 ms, intrahisian second degree A V block during A pacing a rate ≤ 150 b/min) in 6 pts. HP-RP could not be calculated in 8 pts: an AV nodal block occurred after inj. of Am. The HP-A V -conduction was normal in these pts. HP RP were identical in 7 pts, shorter in 2 pts. In these pts the HP-A V -conduction was normal.

In conclusion, intravenous Am lengthened HP RP in 9 pts out of 26 (34%). This effect was more frequent in pts with abnormal HP-A V -conduction. Am should be used with carefulness in pts with abnormalities of HP-conduction. The occurrence of a second or third degree A V block with normal QRS during oral Am therapy indicates an electrophysiological study to determine the level of the block which might be within A V node or HP system.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Podrid P, Lown B: Amiodarone therapy in symptomatic sustained refractory atrial and ventricular tachyarrhythmias. Am Heart J 1981; 101: 374–379.

    Article  CAS  PubMed  Google Scholar 

  2. Rowland E, Krikler D: Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias. Br Heart J 1980; 44: 82–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ward DE, Camm AJ, Spurrell RAJ; Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias. Br Heart J 1980; 44: 91–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Rotmensch H, Belhassen B, Ferguson R: Amiodarone - Benefits and risks in perspective. Am Heart J 1982; 104: 1117–1119.

    Article  CAS  PubMed  Google Scholar 

  5. Wellens H, Brugada P, Roy D, Heddle B, Bar F: A comparison for the electro physiological effects of intravenous and oral amiodarone. Am J Cardiol 1982; 49: 1043.

    Article  Google Scholar 

  6. Derrida JP, Chiche P: Pharmacocinetique des principaux antiarythmiques. Coeur Med Int 1978; 17: 79–88.

    CAS  Google Scholar 

  7. Sebag C, Motte G: Mécanismes d’action cellulaire des medicaments antiarythmiques. Coeur Med Int 1978; 17: 509–519.

    Google Scholar 

  8. Vaughan Williams EM: Intérêt des etudes expérimentales d’antiarythmiques et leur application clinique. Coeur Med Int 1978; 17: 471–489.

    Google Scholar 

  9. Puech P, Cabasson J, Mellet JP, Guimond L, Bachy C, Massine A: Analyse des effects électrophysiologiques de I’amiodarone par l’enregistrement simultané des potentiels d’action monophasique et du faisceau de His. Colloque sur l’amiodarone, Paris, nov 1977: 18–21.

    Google Scholar 

  10. Touboul P, Attalah G, Gressard A, Michelon G, Chatelain MT, Delahaye JP: Effets électrophysiologiques des agents antiarythmiques chez I’homme. Tentative de classification. Arch Mal Coeur 1978: 72–81.

    Google Scholar 

  11. Touboul P, Huerta F, Porte J, Delahaye JP: Bases électrophysiologiques de l’action anitarythmique de I’amiodarone chez l’homme. Arch Mal Coeur 1976; 69: 845–853.

    CAS  PubMed  Google Scholar 

  12. Touboul P, Porte J, Huerta F, Delahaye JP: Electrophysiological effects of amiodarone in man. Am J Cardiol 1975; 35: 173.

    Article  Google Scholar 

  13. Frank R, Fontaine G, Grosgogeat Y: Etude de l’effet antiarythmique de I’amiodarone per os par les méthodes provocatives. Colloque sur I’amiodarone, Paris, Nov 1977: 35–42.

    Google Scholar 

  14. Finerman W, Hamer A, Peter T, Weiss D, Mandel W: Electrophysiologic effects of chronic amiodarone therapy in patients with ventricular arrhythmias. Am Heart 1 1982; 104: 987–995.

    Article  Google Scholar 

  15. Rosenbaum MB, Chiale PA, Halpern MS, Nau GJ, Przybylski J, Levi RJ, Lazzari JO, Elizari MV: Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol 1976; 38: 934–944.

    Article  CAS  PubMed  Google Scholar 

  16. Fauchier JP, Brochier M, Raynaud R: Etude clinique des effets antiarythmiques ventriculaires de I’amiodarone (orale ou injectable). Ann Cardiol Angeiol 1973; 22: 427–435.

    CAS  Google Scholar 

  17. Marcus F, Fontaine G, Frank R, Grosgogeat Y: Clinical pharmacology and therapeutic applications of the antiarrhythmic agent, amiodarone. Am Heart 1 1981; 101: 480–493.

    Article  Google Scholar 

  18. Perrot B, Cherrier F, Faivre G: Valeurs de la période réfractaire antérograde effective du faisceau de His. Arch Mal Coeur 1981; 74: 381–389.

    CAS  PubMed  Google Scholar 

  19. Denes P, Wu D, Dhingra R, Pietras R, Rosen K: The effects of cycle length on cardiac refractory periods in man. Circulation 1974; 49: 32–41.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

K. Steinbach

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

Perrot, B., Zallot, D., Danchin, N., Cherrier, F., Faivre, G. (1983). Effects of Intravenous Amiodarone on Refractory Periods of the His Purkinje System. In: Steinbach, K. (eds) Cardiac Pacing. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-72367-4_107

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72367-4_107

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-642-72369-8

  • Online ISBN: 978-3-642-72367-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics